22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

1987 • 4,980 citations

Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units

1987 • 3,281 citations

SPSS for Windows: base system user's guide release 6.0

1993 • 1,473 citations

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

1981 • 1,025 citations

Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

1987 • 809 citations

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

1984 • 689 citations

A modification of the masson trichrome technique for routine laboratory purposes.

1938 • 488 citations

Renal Osteodystrophy

1995 • 390 citations

Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis

1986 • 389 citations

Renal bone disease 1990: An unmet challenge for the nephrologist

1990 • 358 citations

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1994 • 330 citations

Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure

1989 • 324 citations

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1994 • 316 citations

Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure.

1986 • 302 citations

SPSS for Windows. Base system user's guide.

1994 • 278 citations

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1994 • 255 citations

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

1995 • 246 citations

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.

1989 • 237 citations

Atlas of Mineralized Bone Histology.

1987 • 164 citations

1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial

1989 • 163 citations

Risk of adynamic bone disease in dialyzed patients.

1992 • 152 citations

Synthetic studies of vitamin D3 analogues. VIII Synthesis of 22-oxavitamin D3 analogues.

1986 • 142 citations

On the Mechanisms for the Selective Action of Vitamin D Analogs*

1991 • 139 citations

Regulation of parathyroid hormone synthesis in chronic renal failure in rats

1991 • 139 citations

Synthetic analogues of vitamin D₃ with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia

1987 • 135 citations

Quantitative bone histology in 84 normal American subjects

1982 • 130 citations

EXPERIMENTAL RENAL FAILURE

1932 • 120 citations

A SYNTHETIC ANALOGUE OF VITAMIN D₃, 22-OXA-lα,25-DIHYDROXYVITAMIN D₃IS A POTENT MODULATOR OF IN VIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICE

1989 • 106 citations

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.

1993 • 98 citations

1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats

1996 • 96 citations

The Noncalcemic Analogue of Vitamin D, 22-Oxacalcitriol, Suppresses Parathyroid Hormone Synthesis and Secretion

2015 • 95 citations

Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.

1986 • 94 citations

Human-parathormone assay for use in dogs: validation, sample handling studies, and parathyroid function testing.

1989 • 84 citations

Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines

1996 • 81 citations

Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism

1988 • 66 citations

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

1996 • 66 citations

Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy

1980 • 62 citations

Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.

1990 • 58 citations

New active analogues of vitamin D with low calcemic activity.

1990 • 49 citations

Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression.

1993 • 48 citations

A program package for quantitative analysis of histologic structure and remodeling dynamics of bone

1981 • 45 citations

Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism

1993 • 44 citations

Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2)

1991 • 38 citations

Selective vitamin D analogs and their therapeutic applications.

1994 • 38 citations

22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways

1993 • 35 citations

The effect of 22-oxacalcitriol on serum calcitriol.

1992 • 31 citations

The Activity of 22-Oxacalcitriol in Osteoblast-Like (ROS 17/2.8) Cells*

1991 • 30 citations

Disassociation of the macrophage-maturational effects of vitamin D from respiratory burst priming

1991 • 27 citations

Renal action of cholera toxin: I. Effects on urinary excretion of electrolytes and cyclic AMP

1975 • 24 citations

Effects of 1,25(OH)2D3 administration on bone in patients with renal failure.

1990 • 23 citations

The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.

1983 • 19 citations

Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells

1990 • 18 citations

Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3

1992 • 18 citations

22-oxacalcitriol suppresses 25-hydroxycholecalciferol-1α-hydroxylase in rat kidney

1992 • 18 citations

1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification

1994 • 17 citations

Effects of two new vitamin D3 derivatives, 22-oxa-1α-25-dihydroxyvitamin D3 (OCT) and 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture

1993 • 16 citations

The Effects of Calciferol and its Metabolites on Patients With Chronic Renal Failure

1983 • 13 citations

Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum

1994 • 13 citations

The Effects of Calciferol and Its Metabolites on Patients With Chronic Renal Failure

1983 • 11 citations

Calcitriol administration in end-stage renal disease: intravenous or oral?

1996 • 10 citations

The effect of a new vitamin D analog, 22-oxa-1?,25(OH)2D3, on bone mineral metabolism in normal male rats

1992 • 8 citations

Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice

1996 • 8 citations

Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin

1993 • 8 citations

22-Oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretion

1995 • 5 citations

Effects of 22-oxacalcitriol on bone metabolism in vitro: comparison with calcitriol—Effects of 22-oxacalcitriol on osteoclast-like cell formation and bone-resorbing activity

1995 • 5 citations

Intracellular multiplication of Legionella pneumophila in HL-60 cells functionally differentiated in response to 22-oxacalcitriol

1995 • 3 citations